Cannabis stock market – a worthy investment in 2019
March 6, 2019 (Investorideas.com Newswire) After being banned and considered a potentially dangerous drug for decades, marijuana is now treated like alcohol or tobacco in many countries from around the world. Thanks to the pro-legalization activists that never gave up throughout the years, millions of tax dollars are being raised from its legal sale and an increasing number of small businesses are blooming in this industry at the present.
2018 - A paramount year for the cannabis industry
There have been numerous attempts to decriminalize marijuana in the past, but not many of them were successful. However, the last five years recorded an overwhelming number of less restrictive marijuana laws, including in the United States; and the drug is starting to be seen in a whole new favorable light. Undoubtedly, marijuana history was made in 2018 - a year that set the stage for an outstanding growth of the cannabis stock market for many years to come.
Here are the 2018 highlights you need to know:
- On 1st January, marijuana went legal in California, allowing people 21 and older to use marijuana for both recreational and medical purposes.
- At the end of January, Vermont's governor, Phil Scott, signed a bill legalizing marijuana, making it the first state to do so through its Legislature.
- In October, Canada became the first G7 country to legalize marijuana federally.
- Mexico's Supreme Court followed Canada's lead and allowed the use of marijuana as a right of the citizens to decide their own recreational activities.
- Michigan became the 10th state to legalize recreational marijuana.
- Missouri and Utah approved medicinal marijuana use.
- In December, President Donald Trump signed the bipartisan Farm Bill into law, which legalized hemp.
- In late December, Thailand and New Zealand legalized medicinal marijuana.
- Israel's Parliament approved a law that allowed engaging in medical marijuana exports.
Marijuana remains illegal at the federal level and cannabis companies have to conduct all business in cash. So far, 10 states plus Washington, D.C have legalized marijuana for recreational use and 33 states have legalized it for medical purposes. A handful of other states have similar laws on the books and 2019 holds a promising landscape.
Top Cannabis Stocks to Watch For in 2019
In 2018, some pot stocks uplisted from the OTC exchange to major exchanges, such as the New York Stock Exchange (NYSE). Many small cannabis companies experienced a game-changer growth and are now situated side by side with reputable businesses. Because the marijuana stock market has been under the radar so much in the past year and is growing day by day, make sure you invest in pot stocks with a legit broker. TradeFW.com is a regulated investment firm you can trust and provides you with a wholly legal and secure trading environment, so you can get the best out of a long-term investment.
If you're interested in joining this exciting market, here are the top cannabis stocks to watch for in 2019:
1. Canopy Growth Corp.
Canopy Growth Corp. is a Canadian company that produces and sells high-quality cannabis and cannabis-based products. Its portfolio contains: dried cannabis flowers; cannabis oil products with different ratios of THC and CBD; cannabis in pill form (Softgels), and hemp. Listed and traded on the New York Stock Exchange (NYSE: CGC), as well as on the Toronto Stock Exchange (TSX: WEED) - Canopy Growth is considered one of the biggest pot stocks and has been no.1 in market cap on many occasions, being dethroned by only two major competitors, Tilray and Cronos. This year started on a positive note for the company, as the Canopy stock spiked more than 3% in February, when it announced Martha Stewart will join the company in an advisory role, to help to develop a new line of product offerings for CBD and other cannabinoids' uses. Keep an eye on this stock, it is one of those deal you can't miss!
2. Cronos Group Inc.
Cronos Group is a Canadian-based pot company that operates through its subsidiaries Peace Naturals and Original BC (OBC). The company also owns an interest (21.5% ownership) in Whistler Medical Marijuana Company (WMMC), a brand that produces and sells medical marijuana, as well as cultivates cannabis oil. The wholly-owned brands engage in the same type of activity. Cronos Group was the first cannabis company to be listed on the NASDAQ stock market (NASDAQ: CRON), while also being listed on the Toronto Stock Exchange. This year, the company plans to continue expanding its capacity and is focusing on providing medical marijuana to international markets. There is no question that Cronos is a great buy in 2019!
3. Aurora Cannabis
Aurora Cannabis is Canada's second-largest pot company and it trades on both the Toronto Stock Exchange (TSX: ACB) and New York Stock Exchange (NYSE: ACB). Headquartered in Edmonton, it produces and sells dried cannabis, softgels, and cannabis oils. While it doesn't have Canopy Growth's market share yet and it can't be compared with Crono's revenue - Aurora Cannabis is arguably one of the hottest pot stocks in 2019. Here's why! The last year acquisition of CannaMed and MedReleaf caused its sales to skyrocket 363% to CA$54 million and it became one of the biggest medical marijuana suppliers in Canada. This figure can increase due to the company's potential sales growth and the future plans of substantially increasing production capacity. Aurora Cannabis plans to boost the annual production above 500,000 kilograms and it believes the new production will be at cost below $1 per gram. This stock is worthy to buy for the long haul!
Ground-breaking changes happened in the marijuana industry last year, including in the United States, where cannabis is still illegal at the federal level. The average marijuana stock has risen by more than 100% and this year is projected to bring more positive news. If you want to profit from this booming market; Canopy Growth, Cronos Group and Aurora Cannabis are some of the best-performing pot stocks you can begin with!
Marketing Team at TradeFW.com.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. This article is paid for published third party content and not the content of Investorideas.com . Learn more about posting your articles at http://www.investorideas.com/Advertise/